Colgate-Palmolive (NYSE: CL) CEO exercises options and sells 322,042 shares
Rhea-AI Filing Summary
Colgate-Palmolive Chairman, President & CEO Noel R. Wallace exercised stock options covering 322,042 shares of common stock at an exercise price of $72.2900 per share on August 4–5, 2026, then sold an equal number of shares at weighted average prices of $91.9179 and $92.5215, with a portion of the sale proceeds delivered to the issuer to pay the option exercise price and related tax withholding.
Reported indirect holdings include 54,868 shares held by the issuer's 401(k) plan trustee, 52,000 shares held by a spouse trust, and 335 shares held by another trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 322,042 shares ($6.42M approx. pre-tax spread)
Exercise and Sale
9 txns
Insider
Wallace Noel R.
Role
Chairman, President & CEO
Sold
322,042 shs ($29.70M)
Approx. gross sale proceeds
$29.70M
Approx. exercise cost
$23.28M
Approx. pre-tax spread
$6.42M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F5 | 161,021 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 161,021 | $72.29 | $11.64M |
| Sale | Common Stock F2, F4 | 161,021 | $92.5215 | $14.90M |
| Exercise | Stock Option (Right to Buy) F1, F5 | 161,021 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 161,021 | $72.29 | $11.64M |
| Sale | Common Stock F2, F3 | 161,021 | $91.9179 | $14.80M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 362,231 shares (Direct);
Common Stock — 54,868 shares (Indirect, By Issuer's 401(k) Plan Trustee);
Common Stock — 52,000 shares (Indirect, By Spouse Trust);
Common Stock — 335 shares (Indirect, By Trust)
Footnotes (5)
- F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
- F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
- F3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $91.50 to $92.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $92.00 to $92.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date.
Key Figures
Options exercised: 322,042 shares
Shares sold: 322,042 shares
Option exercise price: $72.2900 per share
+5 more
8 metrics
Options exercised
322,042 shares
Total underlying common shares from derivative exercises on August 4–5, 2026
Shares sold
322,042 shares
Common shares sold on August 4–5, 2026 in open-market transactions
Option exercise price
$72.2900 per share
Exercise price of stock options granted September 12, 2019
August 4, 2026 sale price
$91.9179 per share
Weighted average sale price for 161,021 shares sold August 4, 2026
August 5, 2026 sale price
$92.5215 per share
Weighted average sale price for 161,021 shares sold August 5, 2026
Indirect 401(k) holdings
54,868 shares
Indirect common stock holdings by issuer's 401(k) plan trustee as of August 4, 2026
Indirect spouse trust holdings
52,000 shares
Indirect common stock holdings by spouse trust as of August 4, 2026
Indirect trust holdings
335 shares
Indirect common stock holdings by another trust as of August 4, 2026
Key Terms
Stock Option (Right to Buy), incentive compensation plan, weighted average price, tax withholding
4 terms
Stock Option (Right to Buy) financial
"Security title listed as Stock Option (Right to Buy) for derivative entries"
incentive compensation plan financial
"Footnote notes options were awarded under the issuer's incentive compensation plan"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
weighted average price financial
"Footnotes F3 and F4 describe a weighted average price for multiple sales"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding financial
"Footnote F2 says proceeds covered the exercise price and related tax withholding"
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Colgate-Palmolive (CL) CEO Noel R. Wallace report for August 4–5, 2026?
Noel R. Wallace reported exercising 322,042 stock options at $72.2900 per share and selling an equal number of Colgate-Palmolive common shares at weighted average prices of $91.9179 and $92.5215 over August 4–5, 2026.
How many Colgate-Palmolive (CL) stock options did Noel R. Wallace exercise and at what exercise price?
He exercised options for 322,042 underlying common shares at an exercise price of $72.2900 per share. The options were awarded under Colgate-Palmolive’s incentive compensation plan and became exercisable in one-third increments starting one year after the September 12, 2019 grant date.
How were the proceeds from Noel R. Wallace’s Colgate-Palmolive (CL) stock sales used?
Footnotes state that a portion of the sale proceeds was delivered to Colgate-Palmolive to pay the exercise price of the stock options and the related tax withholding, meaning not all cash from the sales represented net proceeds to Wallace.
Were Noel R. Wallace’s Colgate-Palmolive (CL) trades reported as made under a Rule 10b5-1 trading plan?
The report’s Rule 10b5-1 checkbox is not marked as an affirmative trading plan, and the footnotes do not describe the transactions as made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.